Skip Navigation

Lupus Research Alliance

Teodora Staeva

Lupus Research Alliance Showcases Research that will Shape Next Generation Treatments at ACR Convergence 2025

October 21, 2025

4 original posters to be presented on cell therapy, patient-reported outcomes, innovative recruitment strategies, and clinical trial retention...

Lupus Research Alliance Announces 2025 Empowering Lupus Research Award Recipients to Support Breakthroughs

Early-career and postdoctoral awardees aim to fuel discoveries to improve the lives of people living with lupus Today, the Lupus...

The Rheumatology Research Foundation and the Lupus Research Alliance Join Forces to Offer Funding to Address Lupus

The RRF and LRA Join Forces to Offer Funding to Address Lupus

Amid ongoing fluctuations in federal research funding, a declining physician workforce, and increasing patient needs, the Rheumatology Research Foundation...

Lupus ABC Spearheading a New Era of Collaboration to Advance Lupus Drug Development | Nature Reviews Rheumatology

We are pleased to share an article published in @Nature Reviews Rheumatology highlighting the notable progress and accomplishments of the...

Lupus Research Alliance Announces Recipients of 2024 Diversity in Lupus Research Awards

September 17, 2024

The Lupus Research Alliance (LRA) is pleased to announce the recipients of the 2024 Career Development and Postdoctoral Awards...

Lupus Accelerating Breakthroughs Consortium Announces Expanded Partnership with U.S. FDA at First Anniversary Meeting

The Lupus Research Alliance (LRA), founder and administrator of the Lupus Accelerating Breakthroughs Consortium (Lupus ABC), announced today at...

LRA Announces Partners on the First Anniversary of the Lupus Landmark Study

The Lupus Research Alliance (LRA) and its clinical research affiliate Lupus Therapeutics (LT) are pleased to announce the group...

Lupus Research Alliance and its Clinical Research Affiliate Lupus Therapeutics Launch the Lupus Landmark Study to Accelerate Personalized Treatments in Lupus

NEW YORK, NY. May 23, 2023 – The Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics launched the...

Lupus Research Alliance Unites the U.S. Food & Drug Administration (FDA) & Lupus Community to Launch Novel Public-Private Partnership

Lupus Accelerating Breakthroughs Consortium to address challenges impacting lupus trial success and to accelerate treatment breakthroughs WASHINGTON, DC, March 29,...

Lupus Research Alliance Announces 2022 Dr. William E. Paul Distinguished Innovator Awards Investigating Harmful Immune T Cells

NEW YORK, NY, Dec. 14, 2022. The Lupus Research Alliance (LRA) proudly announces the two outstanding recipients of the...

CAR T Cell Therapy Induces Lupus Remission in Small Study

September 21, 2022 Results of a small study published in the prestigious journal Nature Medicine, suggest that a type of immune...

Lupus Research Alliance Launches Two Major Initiatives to Increase Participation of Underrepresented Minorities in Lupus Clinical Trials and Research

NEW YORK, NY. January 27 — The Lupus Research Alliance (LRA) and clinical affiliate Lupus Therapeutics (LT) announced two major initiatives improving representation...